X
FOLD

Xponance’s Amicus Therapeutics FOLD Stock Holding History

Xponance’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$406K Buy
28,053
+4,521
+19% +$64.8K ﹤0.01% 1102
2025
Q4 		$335K Buy
23,532
+1,643
+8% +$16.1K ﹤0.01% 1124
2025
Q3 		$172K Buy
21,889
+275
+1% +$1.96K ﹤0.01% 1379
2025
Q2 		$124K Sell
21,614
-557
-3% -$3.6K ﹤0.01% 1394
2025
Q1 		$181K Buy
22,171
+955
+5% +$8.84K ﹤0.01% 1284
2024
Q4 		$200K Buy
21,216
+2,249
+12% +$23.4K ﹤0.01% 1300
2024
Q3 		$203K Buy
18,967
+412
+2% +$4.49K ﹤0.01% 1254
2024
Q2 		$184K Buy
18,555
+936
+5% +$9.61K ﹤0.01% 1190
2024
Q1 		$208K Buy
17,619
+434
+3% +$5.55K ﹤0.01% 1184
2023
Q4 		$244K Buy
17,185
+678
+4% +$7.7K ﹤0.01% 1107
2023
Q3 		$201K Buy
16,507
+61
+0.4% +$787 ﹤0.01% 1123
2023
Q2 		$207K Buy
16,446
+461
+3% +$5.47K ﹤0.01% 1141
2023
Q1 		$177K Buy
15,985
+214
+1% +$2.64K ﹤0.01% 1134
2022
Q4 		$193K Buy
15,771
+263
+2% +$2.96K ﹤0.01% 1125
2022
Q3 		$162K Buy
15,508
+605
+4% +$6.74K ﹤0.01% 1093
2022
Q2 		$160K Buy
14,903
+2,396
+19% +$19.7K ﹤0.01% 1110
2022
Q1 		$118K Sell
12,507
-59
-0.5% -$553 ﹤0.01% 1128
2021
Q4 		$145K Buy
12,566
+194
+2% +$2.16K ﹤0.01% 1134
2021
Q3 		$118K Sell
12,372
-1,799
-13% -$18.4K ﹤0.01% 1136
2021
Q2 		$137K Buy
+14,171
New +$138K ﹤0.01% 1200
2020
Q3 		– Sell
-11,866
Closed -$179K – 1031
2020
Q2 		$179K Buy
+11,866
New +$145K ﹤0.01% 986

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Xponance's FOLD Position: Q1 2026 in Review

Xponance increased its Amicus Therapeutics (FOLD) stake by 19% in Q1 2026, buying an estimated $64.8K and bringing the position to 28,053 shares worth $406K. The position accounts for ﹤0.01% of the portfolio, ranked #1102.

Xponance first reported a position in FOLD in Q2 2020 and has held it in 21 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Xponance held 28,053 shares of Amicus Therapeutics worth $406K as of Q1 2026.
  • Xponance bought 4,521 Amicus Therapeutics shares in Q1 2026, an estimated $64.8K.
  • Amicus Therapeutics made up ﹤0.01% of Xponance's portfolio in Q1 2026, its #1102 holding.
  • Xponance first reported a position in Amicus Therapeutics in Q2 2020 and has held it in 21 quarters since.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.